Results 131 to 140 of about 5,195,770 (298)

PAK1 activation drives divergent resistance mechanisms to aromatase inhibition and tamoxifen in a luminal: A breast cancer model

open access: yesMolecular Oncology, EarlyView.
Breast cancer remains a major cause of cancer death in women, frequently developing endocrine therapy resistance. This study demonstrates that upregulated p21‐activated kinase 1 (PAK1) activity drives resistance to tamoxifen and long‐term estrogen deprivation in ER+ breast cancer models.
Luisa Schwarzmüller   +10 more
wiley   +1 more source

Henslee family papers

open access: yes, 1900
This collection contains photographs, albums and miscellaneous documents related to the extended Henslee family of Pine Bluff and Little Rock ...
Henslee family
core   +1 more source

Disfunción temporomandibular en pacientes mayores de 20 años. Policlínico "Ángel Ortiz Vázquez", Manzanillo. 2011-2012

open access: yesRevista Habanera de Ciencias Médicas, 2014
Introducción: Las afecciones en la articulación temporomandibular son de etiología compleja y multifactorial, ocasionando daño a los músculos masticatorios, las estructuras asociadas o ambas.
María Rosa Paneque Gamboa   +3 more
doaj  

Bolling Family Genealogy Chart,

open access: yes, 1939
Handwritten genealogy chart of the Bolling Family, beginning with Pocahontas and John ...
Bolling family
core  

Inhibition of cyclin‐dependent kinases 12/13 using CT7439 as a treatment for colorectal cancer with CDK12 upregulation

open access: yesMolecular Oncology, EarlyView.
The proposed mechanism of action for the CDK12/13 inhibitor and cyclin K degrader, CT7439. CDK12/13 inhibition interrupts transcription elongation, leading to increased DNA damage that results in cell death. This agent is a potentially novel treatment option for patients with colorectal cancer. Created in BioRender. Cyclin‐dependent kinase (CDK) 12 and
Wylie K. Watlington   +10 more
wiley   +1 more source

On the geography of english family names

open access: yesDialectologia: revista electrònica, 2009
The publications dealing with the distributional patterns of English family names in the United Kingdom are anything but numerous and comprehensive. For this task researchers used either different data sets to differing degrees and from different periods in the past or from different current periods.
openaire   +2 more sources

Circulating microRNA signatures of cachexia and cancer in Canis familiaris as a comparative oncology model for human disease

open access: yesMolecular Oncology, EarlyView.
Circulating microRNAs as biomarkers of cachexia and sex‐specific cancer in senior dogs. In 25 client‐owned dogs, four circulating miRNAs (miR‐15a, miR‐15b, miR‐16, miR‐140) were downregulated in cachexia, with miR‐16 the strongest individual biomarker (AUC = 0.899).
Soon‐Seok Park   +6 more
wiley   +1 more source

Preoperative circulating tumor cells integrated with imaging analysis for prognostic evaluation in head and neck squamous cell carcinoma

open access: yesMolecular Oncology, EarlyView.
Detecting circulating tumor cells (CTCs) in blood before surgery may help predict outcomes in patients with head and neck squamous cell carcinoma (HNSCC). Here, we show when combined with tumor size and lymph node involvement from routine imaging, CTC status identifies high‐risk patients with poorer survival—offering a simple, minimally invasive tool ...
Susanne Flach   +9 more
wiley   +1 more source

Családnév-történeti vizsgálatok. A magyar családnévanyag összetétele, típusai, rendszere

open access: yesNévtani Értesítő, 2014
Research into the history of family names. The components, types and system of the Hungarian family-name stock. Summary of a habilitation dissertation     The author’s habilitation dissertation focuses on the concept system and the main types of ...
Tamás Farkas
doaj  

Jolly family

open access: yes, 1878
This record was harvested from a previous catalogue system and will be withdrawn in 2025. Information in this record may be superseded or incomplete.
Armytage Family
core  

Home - About - Disclaimer - Privacy